<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>test</title>
  <link rel="stylesheet" href="styles.css" />
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">
</head>
<body>
  <div class="wrapper">     
        <header class="header-main">
          <div class="header-main-nav">  
            <nav>
                
                <ul>
                <li><a href="index.html">HOME</a></li>
                <li><a href="research.html">RESEARCH</a></li>
                <li><a href="team.html">TEAM</a></li>    
                <li><a href="publication.html">PUBLICATION</a></li>
                <li><a href="news.html">NEWS</a></li>
                <li><a href="funding.html">FUNDING</a></li>
                <li><a href="nous_joindre.html">CONTACT US</a></li>
                </ul>
                </nav>
          </div>          
            <div class="header-main-sm">
                <a href="https://bsky.app/profile/alexapb.bsky.social"><div class="header-main-sm-bs"></div></a>
                <a href="https://www.linkedin.com/in/alexa-pichet-binette-388836b9/?originalSubdomain=ca"><div class="header-main-sm-li"></div></a>
            </div>
            
        </header>
        <div class="banner-container">
            <img src="./Images/publication.jpg" alt="publication banner" class="banner-image">
                <div class="banner-text">PUBLICATION</div>
                </div>
  <section>
    <div class="cards" id="cards">
      <div class="card-publication">
        <img src="./Images/P1.png" alt="">
        <h3>Plasma p-tau markers and vascular factors are associated with cognitive decline and clinical progression in the CIMA-Q cohort</h3>
        <p class="line">Yakoub Y, Qiu T, Peyrot C, Salvadó G, Villeneuve S, Pichet Binette A, Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2025). medRxiv Preprint.</p>
        <p class="comment">This study demonstrates that it is the rate of change in plasma p-tau217, rather than its baseline level, that best predicts the progression of Alzheimer's disease, highlighting its potential as a dynamic marker for monitoring treatment response and Alzheimer's disease progression.This study demonstrates that it is the rate of change in plasma p-tau217, rather than its baseline level, that best predicts the progression of Alzheimer's disease, highlighting its potential as a dynamic marker for monitoring treatment response and Alzheimer's disease 
                progression <br><a href="https://your-publication-link.com" target="_blank" class="read-more">Read full publication</a>
        </p>
        <span class="toggle"><i class="fas fa-chevron-down"></i></span>
      </div>

      <div class="card-publication">
               <img src="./Images/P2.png">
            <h3>Plasma p-tau markers and vascular factors are associated with cognitive decline and clinical progression in the CIMA-Q cohort</h3>
            <p>Yakoub Y, Qiu T, Peyrot C, Salvadó G, Villeneuve S, Pichet Binette A, Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2025). medRxiv Preprint.</p>
            <p class="comment">This study demonstrates that it is the rate of change in plasma p-tau217, rather than its baseline level, that best predicts the progression of Alzheimer's disease, highlighting its potential as a dynamic marker for monitoring treatment response and Alzheimer's disease progression.This study demonstrates that it is the rate of change in plasma p-tau217, rather than its baseline level, that best predicts the progression of Alzheimer's disease, highlighting its potential as a dynamic marker for monitoring treatment response and Alzheimer's disease progression<br><a href="https://your-publication-link.com" target="_blank" class="read-more">Read full publication</a></p>
            <span class="toggle"><i class="fas fa-chevron-down"></i></span>
        </div> 

      <div class="card-publication">
        <img src="./Images/P3.png" alt="">
        <h3>Trajectories of plasma biomarkers, amyloid-beta burden and cognitive decline in Alzheimer’s disease: A Longitudinal ADNI Study</h3>
        <p class="line">Villeneuve S, Poirier J, Breitner JCS, Tremblay-Mercier J, Remz J, Raoult JM, Yakoub Y, Gallego-Rudolf J, Qiu T, Fajardo Valdez A, Mohammediyan B, Javanray M, Metz A, Sanami S, Ourry V, Wearn A, Pastor-Bernier A, Edde M, Gonneaud J, Strikwerda-Brown C, Tardif CL, Gauthier CJ, Descoteaux M, Dadar M, Vachon-Presseau É, Baril AA, Ducharme S, Montembeault M, Geddes MR, Soucy JP, Rajah N, Laforce R, Bocti C, Davatzikos C, Bellec L, Rosa-Neto P, Baillet S, Evans AC, Collins DL, Chakravarty MM, Blennow K, Zetterberg H, Spreng RN, Pichet Binette A; PREVENT‐AD Research Group (2025).</p>
        <p class="comment">
          The PREVENT-AD study is a 12-year longitudinal cohort of cognitively normal older adults at risk for Alzheimer’s disease, now sharing an expanded multimodal dataset, including cognitive, behavioral, plasma, PET, MEG, and MRI measures to advance global research on the presymptomatic stages and progression of AD.
          <br><a href="https://example.com" target="_blank" class="read-more">Read full publication</a>
        </p>
        <span class="toggle"><i class="fas fa-chevron-down"></i></span>
      </div>
      <div class="card-publication">
        <img src="./Images/P4.png" alt="">
        <h3>Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease</h3>
        <p class="line">Pichet Binette A, Smith R, Salvadó G, Tideman P, Glans I, van Westen D, Groot C, Ossenkoppele R, Stomrud E, Parchi P, Zetterberg H, Blennow K, Mattsson-Carlgren N, Janelidze S, Palmqvist S, Hansson O, & Alzheimer’s Disease Neuroimaging Initiative (2025). JAMA neurology</p>
        <p class="comment">This study shows that individuals with clinical impairment greater than their biological stage of Alzheimer's disease often have additional pathologies, such as α-synuclein, TDP-43-related atrophy, and small vessel disease, highlighting the crucial role of co-pathologies in symptom severity and the need to evaluate non-AD-related biomarkers for accurate diagnosis and prognosis.<br><a href="https://example.com" target="_blank" class="read-more">Read full publication</a>
        </p>
        <span class="toggle"><i class="fas fa-chevron-down"></i></span>
      </div>
    </div>
  </section>
 <footer>
    <div class="container-footer-contact">
        <div class="footer-contact-img">
            <img src="./Images/udm.png" alt="IUGM">
        </div>
        
        <div>
            <table> 
               <tr>
                   <td>Centre de recherche IUGM</td>
               </tr> 
               <tr>
                   <td>4545 chemin Queen-Mary</td>
               </tr>
               <tr> 
                   <td>Montreal, Quebec</td>
               </tr>
                <tr>
                    <td>Canada H3W 1W5</td>
               </tr>
               <tr> 
                    <td>Office : M6829</td>
               </tr>
                <tr> 
                    <td>Email: 
                    <a href="mailto:alexa.pichet.binette@umontreal.ca">alexa.pichet.binette@umontreal.ca</a>
                    </td>
               </tr>
            </table> 
                    
        </div>
        <div class="footer-contact-img">
            <img src="./Images/iugm-logo9.png" alt="IUGM">
        </div>
    </div> 
    <div class="MB">
        <span class="mb-left">Version 0.1</span>
        <span class="mb-center">Created by MB</span>
    </div>
      
    </footer>
    </div>
  <script>
    const container = document.getElementById('cards');

    container.addEventListener('click', (e) => {
      const toggle = e.target.closest('.toggle');
      if (!toggle) return;

      const card = toggle.closest('.card-publication');
      const comment = card.querySelector('.comment');
      const lineHeight = parseFloat(getComputedStyle(comment).lineHeight);
      const collapsedHeight = 4 * lineHeight;

      // Collapse any other open comments
      container.querySelectorAll('.card-publication .comment.open').forEach(other => {
        if (other !== comment) {
          const current = other.scrollHeight;
          other.style.height = current + 'px';
          other.classList.remove('open');
          requestAnimationFrame(() => {
            other.style.height = collapsedHeight + 'px';
          });
          other.addEventListener('transitionend', function onEnd() {
            other.style.height = '';
            other.removeEventListener('transitionend', onEnd);
          }, { once: true });
        }
      });

      // Toggle the clicked one
      const isOpen = comment.classList.contains('open');
      if (!isOpen) {
        comment.classList.add('open');
        comment.style.height = collapsedHeight + 'px'; // ensure start height
        const target = comment.scrollHeight;
        requestAnimationFrame(() => {
          comment.style.height = target + 'px';
        });
        comment.addEventListener('transitionend', function onEnd() {
          comment.style.height = 'auto'; // natural after animation
        }, { once: true });
      } else {
        const current = comment.scrollHeight;
        comment.style.height = current + 'px';
        comment.classList.remove('open');
        requestAnimationFrame(() => {
          comment.style.height = collapsedHeight + 'px';
        });
        comment.addEventListener('transitionend', function onEnd() {
          comment.style.height = '';
        }, { once: true });
      }
    });
  </script>
</body>
</html>